Agrylin

In the US, Agrylin (anagrelide systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Chronic Myelogenous Leukemia and Thrombocythemia.

US matches:

• Agrylin

Ingredient matches for Agrylin

Anagrelide

Anagrelide hydrochloride (a derivative of Anagrelide) is reported as an ingredient of Agrylin in the following countries:

• Australia


• Canada


• Indonesia


• Israel


• South Africa


• Taiwan


• United States

International Drug Name Search